4.6 Article

Antiprotozoal compounds from Mikania periplocifolia (Asteraceae)

Related references

Note: Only part of the references are listed.
Review Microbiology

Anti-trypanosomatid drug discovery: progress and challenges

Manu De Rycker et al.

Summary: Leishmaniasis, Chagas disease, and human African trypanosomiasis are major causes of death and illness, particularly in low- and middle-income countries. The development of new medicines for leishmaniasis and Chagas disease is urgently needed, with limited progress in the clinical pipeline for Chagas disease. This review provides an overview of recent advances in understanding the biology of these pathogens, with a focus on drug discovery, as well as the development of new drug candidates and potential solutions to overcome challenges in clinical development.

NATURE REVIEWS MICROBIOLOGY (2023)

Article Pharmacology & Pharmacy

Anti-Trypanosoma cruzi Properties of Sesquiterpene Lactones Isolated from Stevia spp.: In Vitro and In Silico Studies

Jimena Borgo et al.

Summary: Stevia species, particularly S. satureiifolia var. satureiifolia and S. alpina, are rich in terpenoid compounds with antiprotozoal activity. Two sesquiterpene lactones, santhemoidin C and 2-oxo-8-deoxyligustrin, were isolated and evaluated for their trypanocidal activity against Trypanosoma cruzi. Santhemoidin C showed promising inhibitory activity against the parasite's different stages and the Tc80 protein, making it a potential candidate for the development of trypanocidal drugs.

PHARMACEUTICS (2023)

Review Chemistry, Medicinal

The Potential of Secondary Metabolites from Plants as Drugs or Leads against Trypanosoma cruzi-An Update from 2012 to 2021

Henrique Barbosa et al.

Summary: Chagas disease is a neglected tropical disease mainly affecting Latin America, but immigration has spread the disease to other continents. This review explores the anti-T. cruzi compounds isolated from plants in the past decade, and discusses computational approaches and challenges in natural product drug discovery.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2023)

Review Microbiology

Anti-trypanosomatid drug discovery: progress and challenges

Manu De Rycker et al.

Summary: Leishmaniasis, Chagas disease, and human African trypanosomiasis are causing significant death and morbidity, especially in low- and middle-income countries. There is a critical need for new medications for leishmaniasis and Chagas disease, while the clinical development pipeline for Chagas disease remains sparse. This review discusses recent advancements in understanding the biology of these pathogens, with a focus on drug discovery, and explores progress in developing new drug candidates and identifying potential molecular targets. The challenges in developing new clinical candidates are also discussed, along with potential solutions to overcome these hurdles.

NATURE REVIEWS MICROBIOLOGY (2023)

Review Chemistry, Medicinal

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets

Fernando Altamura et al.

Summary: Human trypanosomiasis and leishmaniasis, caused by protozoan parasites, have become globally distributed tropical diseases due to human migration, climate change, and anthropogenic disturbance. The current chemotherapy for these diseases has limited efficacy and drug resistance is a growing concern. This review discusses the limitations of available drugs and highlights promising leads from current drug-based clinical trials. It also examines the challenges in target-based drug discovery and the advantages and limitations of modern research tools.

DRUG DEVELOPMENT RESEARCH (2022)

Article Plant Sciences

Mode of action of the sesquiterpene lactones eupatoriopicrin and estafietin on Trypanosoma cruzi

Orlando G. Elso et al.

Summary: The study demonstrates that both eupatoriopicrin and estafietin have additive effects on T. cruzi, suggesting that each compound acts on different primary targets. The combination treatment of eupatoriopicrin and estafietin could be considered a promising alternative for the treatment of Chagas' disease.

PHYTOMEDICINE (2022)

Review Biochemistry & Molecular Biology

Antimalarial Drug Discovery: From Quinine to the Most Recent Promising Clinical Drug Candidates

Camille Tisnerat et al.

Summary: Malaria is a tropical disease caused by Plasmodium parasites, resulting in 409,000 deaths in 2019. The spread of drug resistant parasites from Southeast Asia has further complicated the mortality and morbidity. The emergence of artemisinin-resistant Plasmodium in Africa, where most cases occur, has highlighted the urgent need for new medicines. This review focuses on the ongoing search for new antimalarial drugs, particularly in terms of medicinal chemistry and the development of promising candidates in clinical and preclinical phases.

CURRENT MEDICINAL CHEMISTRY (2022)

Review Dermatology

Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments

Henry J. C. de Vries et al.

Summary: This article is an update of a previous review on the clinical management of cutaneous leishmaniasis (CL), covering diagnosis, treatment, prevention, and control. CL is a global problem, affecting 12 million cases with 2 million new cases annually. Local experience and species determination are crucial for effective management. However, there is a lack of large and well-conducted studies on treatment options, especially for children. Improved vector control, diagnostics, and safe vaccines are urgently needed, but limited investment from biotechnical companies hinders progress.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Global, Regional, and National Trends of Chagas Disease from 1990 to 2019: Comprehensive Analysis of the Global Burden of Disease Study

Sergio Alejandro Gomez-Ochoa et al.

Summary: The global burden of Chagas disease has changed in recent decades, with a sustained decline in the number of cases. While the majority of cases remain concentrated in Latin America, the increase observed in North America and Europe highlights the importance of screening and raising awareness among at-risk populations.

GLOBAL HEART (2022)

Review Biochemistry & Molecular Biology

Current leishmaniasis drug discovery

Alessandra Campbell Pinheiro et al.

Summary: Leishmaniasis is a complex infectious disease that affects neglected populations. Current drug regimens are outdated and there is a need for the development of new, effective and less toxic drugs. The pathogenesis of leishmaniasis is not well understood and there is a lack of prophylactic vaccines. Recently, new drug targets have been identified and new compounds have shown promising antileishmanial activities, offering hope for future control of this disease burden.

RSC MEDICINAL CHEMISTRY (2022)

Article Parasitology

Dihydroartemisinin, an active metabolite of artemisinin, interferes with Leishmania braziliensis mitochondrial bioenergetics and survival

Nathalia Grazzia et al.

Summary: Leishmaniasis, a neglected parasitic infection, may be effectively treated with artemisinin and its derivatives, which show high sensitivity to Leishmania braziliensis. These compounds exhibit cytotoxic effects on bone marrow-derived macrophages and are likely to act through mitochondrial bioenergetics and H2O2 production to kill the parasites. This suggests a potential for the repositioning of artemisinin and its derivatives in experimental leishmaniasis treatment.

PARASITOLOGY RESEARCH (2021)

Review Biochemistry & Molecular Biology

Advances in Drug Discovery against Neglected Tropical Diseases: Human African and American Trypanosomiasis

Mudasir Nabi Peerzada et al.

Summary: This review discusses drug development strategies for human African and American trypanosomiasis, highlighting the most promising compounds identified through various approaches and emphasizing the potential of molecular hybridization in preventing the development of resistance.

CURRENT MEDICINAL CHEMISTRY (2021)

Review Microbiology

Natural-Product-Based Solutions for Tropical Infectious Diseases

Oyelola Adegboye et al.

Summary: This review discusses infectious diseases specific to the tropics, current treatments, biodiscovery potential of the tropical biome, and technologies for drug development from natural resources. It emphasizes the impact of natural products from the tropical biome in treating tropical infectious diseases and the role of high-throughput technical capacity in accelerating the discovery process.

CLINICAL MICROBIOLOGY REVIEWS (2021)

Review Infectious Diseases

A Review of Leishmaniasis: Current Knowledge and Future Directions

Sarah Mann et al.

Summary: This review summarizes the current knowledge of cutaneous, mucosal, and visceral leishmaniasis in terms of epidemiology, clinical manifestations, diagnosis, and treatment. The article also discusses newer tests, vaccine candidates, and updated treatment recommendations for leishmaniasis. Understanding the prominent clinical manifestations and major parasite species can help guide recommendations for diagnosis and treatment of this complex disease.

CURRENT TROPICAL MEDICINE REPORTS (2021)

Review Plant Sciences

Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2020)

Article Biochemistry & Molecular Biology

Trypanocidal Activity of Four Sesquiterpene Lactones Isolated from Asteraceae Species

Orlando G. Elso et al.

MOLECULES (2020)

Review Biochemistry & Molecular Biology

Challenges in Chagas Disease Drug Development

Amanda F. Francisco et al.

MOLECULES (2020)

Article Biochemistry & Molecular Biology

Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis

Valeria P. Sulsen et al.

MOLECULES (2019)

Review Chemistry, Medicinal

Leishmaniasis and Chagas Disease - Neglected Tropical Diseases: Treatment Updates

Leandro Stefano Sangenito et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease

Roberval Nascimento Moraes Neto et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Clinical Neurology

Update on human African trypanosomiasis (sleeping sickness)

Peter G. E. Kennedy

JOURNAL OF NEUROLOGY (2019)

Review Public, Environmental & Occupational Health

Chagas Disease: From Discovery to a Worldwide Health Problem

Karita Claudia Freitas Lidani et al.

FRONTIERS IN PUBLIC HEALTH (2019)

Review Chemistry, Medicinal

Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue

Pone Kamdem Boniface et al.

PHYTOTHERAPY RESEARCH (2019)

Review Plant Sciences

Sesquiterpene Lactones: More Than Protective Plant Compounds With High Toxicity

Guillermo Federico Padilla-Gonzalez et al.

CRITICAL REVIEWS IN PLANT SCIENCES (2016)

Article Chemistry, Applied

Active sesquiterpene lactones against Leishmania amazonensis and Leishmania braziliensis

Andrea M. Sosa et al.

NATURAL PRODUCT RESEARCH (2016)

Article Integrative & Complementary Medicine

Trypanocidal Activity of Smallanthus sonchifolius: Identification of Active Sesquiterpene Lactones by Bioassay-Guided Fractionation

F. M. Frank et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

Article Infectious Diseases

Natural Terpenoids from Ambrosia Species Are Active In Vitro and In Vivo against Human Pathogenic Trypanosomatids

Valeria P. Suelsen et al.

PLOS NEGLECTED TROPICAL DISEASES (2013)

Review Biochemistry & Molecular Biology

Flavonoids in Subtribe Centaureinae (Cass.) Dumort. (Tribe Cardueae, Asteraceae): Distribution and 13C-NMR Spectral Data

Carmen Formisano et al.

CHEMISTRY & BIODIVERSITY (2012)

Article Multidisciplinary Sciences

In Vitro Evaluation of Antiprotozoal and Antiviral Activities of Extracts from Argentinean Mikania Species

Laura C. Laurella et al.

SCIENTIFIC WORLD JOURNAL (2012)

Article Chemistry, Organic

The Metabolites of the Genus Onopordum (Asteraceae): Chemistry and Biological Properties

Maurizio Bruno et al.

CURRENT ORGANIC CHEMISTRY (2011)

Article Infectious Diseases

Psilostachyin C: a natural compound with trypanocidal activity

Valeria P. Suelsen et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)

Article Microbiology

Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae)

Valeria P. Sulsen et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)

Article Public, Environmental & Occupational Health

Trypanocidal and leishmanicidal activities of flavonoids from argentine medicinal plants

Valeria P. Suelsen et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)

Article Plant Sciences

Screening of southeastern Brazilian Mikania species on Trypanosoma cruzi

Juliana Siqueira Chaves et al.

PHARMACEUTICAL BIOLOGY (2007)